Загрузка...
Combined effects of synbiotic and sitagliptin versus sitagliptin alone in patients with nonalcoholic fatty liver disease
BACKGROUND/AIMS: Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent chronic liver diseases in recent years. The aim of this study was to evaluate the effects of sitagliptin with and without a synbiotic supplement in the treatment of patients with NAFLD. METHODS: In total, 138 NAF...
Сохранить в:
| Опубликовано в: : | Clin Mol Hepatol |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
The Korean Association for the Study of the Liver
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6166102/ https://ncbi.nlm.nih.gov/pubmed/29890569 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2018.0006 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|